By the French Council Communist journal "Pour le Pouvoir International des Conseils Ouvriers" [PPICO], this text takes a shot ...

Announced rosnilimab, a PD-1 depleter and agonist, achieved positive results from Phase 2b rheumatoid arthritis (RA) trial and highest-ever ...

Targeting NDA submission for bitopertin in erythropoietic protoporphyria (EPP) in H2 2025 through accelerated approval ...

In September 2024, Athira announced topline results from the LIFT-AD Phase 2/3 clinical trial of fosgonimeton in ...

ACCESS and ACCESS II studies fully enrolled; topline data from both studies anticipated by year-end 2025Oral small ...

Notion and the many apps competing with it are an expression of that idea. It's an app that lets you build the functionality ...

Revenue was $567.4 Million, down 9.4 PercentNet Income was $4.6 Million or 0.8 Percent of Revenue($9.0 Million or 1.6 Percent of Revenue Non-GAAP)Adjusted EBITDA was $50.9 Million or 9.0 Percent of ...

As the European Commission president prepares for her visit to New Delhi, leading advocacy groups are sounding the alarm. They warn that in its pursuit of stronger diplomatic ties, Brussels must not ...

IMNN-001 remains the first immunotherapy to achieve a meaningful overall survival benefit in advanced ovarian cancer Patient enrollment in Phase 3 pivotal trial of IMNN-001 scheduled to begin in Q1 ...

Q4 2024 Results Conference Call February 26, 2025 11:00 AM ETCompany ParticipantsPeter Vozzo - ICR Healthcare, IRStacy Lindborg ...

This is the Dollar Tree at 3489 W 86th St in Indianapolis, Indiana – a veritable treasure trove of bargains that’ll make your ...

Financial Guidance: Celldex believes that the cash, cash equivalents and marketable securities at December 31, 2024 are sufficient to meet estimated working capital requirements and fund current ...